Inhibitor Therapeutics   Report issue

For profit Phase 2
Founded: Tampa FL United States (1992)
Status: Left NME R&D (2020)

Organization Overview

First Clinical Trial
2015
NCT02354261
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now